Vascular Disease, Peripheral Clinical Trial
Official title:
Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System
The occurrence of Peripheral Vascular Disease has been increasing which includes the large artery in the upper leg called Superficial Femoral Artery (SFA). The Peritoneal Lined Stent has been developed as a new method for treating narrowed area in the SFA. This research study will determine the safety and effectiveness of the Peritoneal Lined Stent in keeping th Superficial Femoral Artery open and allowing blood to flow in the leg.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05783700 -
Identification of Biomarkers for the Study of the Diabetic Foot and Evolution.
|
||
| Completed |
NCT02135848 -
3 Month PHI PAD PoM Study
|
Phase 2 | |
| Completed |
NCT05710653 -
Inter-individual Physiological Response to a Training and Detraining Period in Cardiometabolic Risk Factors Subjects
|
N/A | |
| Terminated |
NCT00518284 -
Prevention of Restenosis Following Revascularization
|
Phase 2 | |
| Completed |
NCT04585763 -
Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System
|
N/A | |
| Not yet recruiting |
NCT05843929 -
Prevalence of the Appearance of Diabetic Ulcers in Patients With 3D Insole and LSCI.
|
N/A | |
| Recruiting |
NCT05860764 -
Vascular Amputee Physical Performance Qualitative (VAmPP-Q) Study
|
||
| Recruiting |
NCT05720156 -
Immunomodulatory Effects of PCSK9 Inhibition
|
||
| Completed |
NCT04146493 -
Heparin-Binding Protein and Heparins
|